Leading Indian Pharma Companies Maintain Strong Growth

Several big names in the Indian pharmaceutical industry have reported strong earnings and sales growth in the first quarter. New product launches, better results from international markets, and revenues from acquired companies have boosted growth, companies say. Wockhardt: Sales are up. Ranbaxy Laboratories (Gurgaon), India’s biggest pharma company, posted a 79% increase in net profits, to $29 million, compared with the year-ago period. Sales for the quarter were up 23%, to $355 million. “Robust growth across geographies driven by new product flow in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers